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Abstract
Modulation of human cardiac mechanical and electrophysiologic function by
direct stellate ganglion stimulation has not been performed. Our aim was to
assess the effect of low-level left stellate ganglion (LSG) stimulation (SGS) on
arrhythmias, hemodynamic, and cardiac electrophysiological indices. Patients
undergoing ablation procedures for arrhythmias were recruited for SGS. A
stimulating electrode was placed next to the LSG under fluoroscopy and ultra-
sound imaging; and SGS (5–10 Hz, 10–20 mA) was performed. We measured
hemodynamic, intracardiac and ECG parameters, and activation recovery
intervals (ARIs) (surrogate for action potential duration) from a duodecapolar
catheter in the right ventricular outflow tract. Five patients underwent SGS (3
males, 45  20 years). Stimulating catheter placement was successful, and
without complication in all patients. SGS did not change heart rate, but
increased mean arterial blood pressure (78  3 mmHg to 98  5 mmHg,
P < 0.001) and dP/dt max (1148  244 mmHg/sec to 1645  493 mmHg/
sec, P = 0.03). SGS shortened mean ARI from 304  23 msec to
283  17 msec (P < 0.001), although one patient required parasympathetic
blockade. Dispersion of repolarization (DOR) increased in four patients and
decreased in one, consistent with animal models. QT interval, T-wave dura-
tion and amplitude at baseline and with SGS were 415  15 msec versus
399  15 msec (P < 0.001); 201  12 msec versus 230  28 msec; and
0.2  0.09 mV versus 0.22  0.08 mV, respectively. At the level of SGS per-
formed, no increase in arrhythmias was seen. Percutaneous low-level SGS
shortens ARI in the RVOT, and increases blood pressure and LV contractility.
These observations demonstrate feasibility of percutaneous SGS in humans.
Introduction
The autonomic nervous system powerfully regulates all
aspects of cardiac function, and its electrophysiology
(Vaseghi and Shivkumar 2008). Excitation of the sympa-
thetic nervous system (SNS) has been linked to atrial
and ventricular arrhythmogenesis (Schwartz 2014; Shen
and Zipes 2014). In animal models, direct electrical and
chemical stimulation of neural elements within the car-
diac sympathetic nervous system, most commonly the
stellate ganglia, have provided significant insights into
the possible mechanisms by which sympathoexcitation-
mediated arrhythmias originate in humans (Yanowitz
et al. 1966; Meyer et al. 2010; Ramirez et al. 2011; Ajij-
ola et al. 2013b). Pharmacologic and reflex sympathetic
stimulation (Vaseghi et al. 2012), as well as anesthetic
blockade of the stellate ganglia have also been used to
modulate ventricular electrophysiology and to treat
arrhythmias (Schwartz et al. 1976; Cinca et al. 1985;
Fujii et al. 2004; Tan et al. 2012), however, studies on
direct stimulation of the sympathetic nervous system in
humans are lacking.
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the American Physiological Society and The Physiological Society.
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
2015 | Vol. 3 | Iss. 3 | e12328
Page 1
Physiological Reports ISSN 2051-817X
High-frequency electrical stimulation in the proximal
pulmonary artery in humans induces premature ventricu-
lar contractions (PVCs) from the right ventricular outflow
tract in the presence of dobutamine (Hasdemir et al.
2009). Mental stress has also been shown to shorten
action potential duration (APD). Prolongation of the QT
interval was also observed following application of radio-
frequency energy to the stellate ganglia during surgery in
patients with palmar hyperhidrosis (Wong 1997). Percu-
taneous stimulation of stellate ganglia (SGS) in humans
and the assessment of myocardial electrophysiologic
parameters however, have not been performed. In this
study, we report the feasibility of percutaneous low-level
SGS for studying the modulation of cardiac function and
electrophysiology by sympathoexcitation in humans.
Methods
Patient population
The study population included five patients referred for
cardiac electrophysiologic procedures. The study was
approved by the UCLA Institutional Review Board (IRB).
All patients received the consent form for the study to
review >1 week before presenting for the procedure and
written informed consent was signed by all patients.
Detailed clinical history, examination, and echocardio-
graphic assessment were performed. Two of five patients
were on antiarrhythmic medications; oral Metoprolol Tar-
trate 25 mg twice daily (held for 1 week prior) in one
patient; and carvedilol 12.5 mg twice daily in another
patient. None of the patients had a history of autonomic
disorders, and had not previously undergone any neuro-
modulation procedures.
Electrophysiologic study
Monitored Anesthesia Care (MAC) was provided to all
study patients using intravenous propofol infusions (50–
100 mcg/kg/min), titrated to moderate sedation. Supple-
mental oxygen via facemask was delivered to all patients.
Electrophysiologic catheters were placed via percutaneous
vascular access (via right internal jugular or femoral
venous access). An arterial sheath (4F) was placed in the
femoral artery. All patients had continuous 12-lead elec-
trocardiographic recordings. A decapolar catheter was
placed in the coronary sinus, while quadripolar catheters
were placed in the high right atrial, right ventricular, and
His bundle positions under fluoroscopic guidance. From
the His bundle catheter, atrioventricular conduction
[Atrial to His signals (AH interval)] and His-Purkinje
conduction [His signal to earliest electrocardiographic
QRS complex (HV interval)] were measured. A duodeca-
polar catheter (20-pole) was placed in the right ventricu-
lar outflow tract.
Stellate ganglion stimulation was performed prior to
the electrophysiology study and catheter ablation.
Catheter placement and stellate ganglion
stimulation
Once the patients were under MAC, a stimulating periph-
eral nerve catheter for left SGS was inserted via Tuohy
needle as recently described Abdi et al. (2004). In the
supine position, the patient’s head was extended, and
rotated slightly to the right. The skin was cleaned with
chlorhexidine prior to application of sterile drapes. Using
anterior-posterior fluoroscopy, the C5-6 disk was well
visualized, then the left C6 and C7 were identified. Using
a linear ultrasound probe (Narouze et al. 2007), the tra-
chea, thyroid, carotid, and internal jugular vein were
identified at the C6 level. Lidocaine (1%) was injected to
anesthetize skin. With the bevel directed caudal and lat-
eral, an 8 cm, insulated Tuohy-tip needle (Stimucath,
Arrow International) was inserted through the lidocaine
skin wheel. Using ultrasound guidance, the needle tip was
advance so that the needle tip was anterior to the longus
colli muscle and avoiding vascular structures and adjacent
to T1. After negative aspiration, 1 mL of contrast was
injected and checked under fluoroscopy to show adequate
spread without vascular entry. 19G StimuCath catheter
was then placed through the Tuohy needle. Placement of
the StimuCath catheter was confirmed with fluoroscopy
between the left C7-T1 levels. The Tuohy needle was
removed carefully out of the skin and the catheter was
secured with Tegaderm dressing. A nerve-stimulating clip
was attached to the proximal end of the nerve-stimulating
catheter and attached to an external pulse generator for
stimulation (Model #5388, Medtronic, Minneapolis, MN).
Stimulation was initiated at 5 Hz, 5 mA and titrated
until a hemodynamic response was observed (increase in
blood pressure), typically >20–30 sec of stimulation. Stim-
ulation parameters for each subject are shown in the table.
From the arterial line, hemodynamic monitoring was
performed, and a >10% increase in mean arterial pressure
was used as a marker for SGS. From the arterial pressure
waveform, the rate of rise in pressure over time (dP/dt)
was taken as a surrogate for contractility, as it was not
measured directly with conductance catheter.
Data acquisition and activation recovery
interval analysis
Unipolar electrograms were recorded from the duodeca-
polar catheter placed in the right ventricular outflow tract
using an electrophysiologic acquisiton system (Cardiolab
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Electrophysiologic Recording System, General Electric,
Fairfield, CT). Recordings were filtered at 0.05–500 Hz.
Activation recovery interval (ARI) analysis was performed
as previously described Ajijola et al. (2013b).
Statistical analysis
Values are expressed as mean  standard error. ARIs
before and during SGS in the same subject were analyzed
with a Wilcoxon signed-rank test. Comparisons with
more than two groups were performed with the Welch’s
ANOVA, given the non-normal distribution. The values
across subjects were compared using the one-tailed Wil-
coxon signed-rank test. A P value ≤0.05 was considered
statistically significant.
Results
Patient characteristics
Five patients referred for electrophysiology study and
ablation underwent SGS (age 45  20 years; three males).
The characteristics of the study patients are shown in the
table. All patients had structurally normal hearts, mean
left ventricular ejection fraction 62  3.6%. Percutaneous
placement of the SGS Catheter was successful in all
patients (Fig. 1A) and no complications occurred. Elec-
trophysiologic catheters were placed as demonstrated in
Fig. 1B. Long-term follow up of all patients (16–
28 months poststimulation) has shown no late complica-
tion following SGS.
Hemodynamic and intracardiac conduction
responses to SGS
Stimulation was initiated at 5 Hz and 5 mA for
20–60 sec, and was confirmed by the appearance of stim-
ulation artifact saturating the electrocardiographic and
intracardiac electrogram channels (Fig. 2A). The fre-
quency and output were increased gradually after a brief
poststimulation reequilibration period (1–5 min), until a
hemodynamic response occurred (≥10% increase in mean
arterial pressure) (Fig. 2A). Stimulation parameters at
which this hemodynamic response occurred are listed in
Table 1. The intention was low-level SGS, therefore, stim-
ulation parameters were not increased further.
SGS increased systolic blood pressure (120.8  5.3
mmHg vs. 144.4  9.2 mmHg, P < 0.001); diastolic
blood pressure (58.4  2.6 mmHg vs. 76.4  4.3 mmHg,
P < 0.001); mean arterial pressure (78.8  2.8 mmHg vs.
98.6  5.4 mmHg, P < 0.001); and pulse pressure (62.4
 5.3 mmHg vs. 68  7.2 mmHg, P < 0.001) (Fig. 2C).
SGS also increased dP/dtmax (a surrogate for cardiac
contractility) from 1148  244 mmHg/sec to 1645 
493 mmHg/sec (P = 0.03).
SGS did not significantly affect heart rate (70.8  5
beats/min vs. 73.3  6 beats/min, P = 0.15) but short-
ened the AH interval (100.8  6.6 msec vs. 88.5  5.3
msec, P < 0.001), and did not significantly affect the HV
interval (47.8  4.3 msec vs. 47.3  3.2 msec, P = 0.2)
(Fig. 2D).
SGS induces ARI shortening
A representative example of ARI shortening with SGS is
shown in Fig. 2B. Mean ARI at baseline across all subjects
was 303.7  22.5 msec. Individual responses to SGS are
shown in Fig. 3A. Mean ARI shortened in all subjects
except subject one, in whom a trend toward an increase
in ARI was observed. This subject also had the highest
ARI at baseline (370 msec vs. 230–320 msec for the other
subjects). To exclude the potential of parasympathetic
influence, atropine 1 mg was administered. Atropine
resulted in a slight increase in ARI (364  6 msec vs.
371  12 msec, P = 0.03) (Fig. 3C). SGS, in the presence
of atropine, resulted in a significant shortening in ARI
(371  12 msec vs. 330  20.9 msec, P < 0.001). In all
the other subjects, SGS resulted in ARI shortening
(Fig. 3A), without need for atropine. Dispersion of ARI
across all electrodes, taken as the difference between the
maximum and minimum ARI values was increased in all
patients except one (Fig. 3B).
Influence of SGS on electrocardiographic
parameters
From the 12-lead electrocardiogram recorded by the Car-
diolab system, the QT and corrected QT (QTc) intervals;
RR interval; T-wave duration and amplitude; and Tpeak-
Tend duration were measured. SGS shortened QT interval
(515.3  15.1 msec vs. 399.6  15 msec, P < 0.001) but
did not significantly change QTc (447.9  5 msec vs.
437.9  7.3 msec, P > 0.2); R-R interval (865.3  64.3
msec vs. 841.3  72.9 msec, P > 0.2); T-wave duration
(201  12 msec vs. 229.8  27.6 msec, P > 0.2); or
T-wave amplitude (0.2  0.09 mV vs. 0.22  0.08 mV,
P > 0.2) (Fig. 4).
Discussion
The main findings of the present study are as follows: (1)
low-level SGS using a percutaneous ultrasound- and fluo-
roscopy-guided stimulating catheter is feasible, does not
result in severe arrhythmias, and can be safely achieved
without complications; low-level left SGS results in (2)
inotropic but not chronotropic response; (3) predomi-
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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nantly an increase in repolarization heterogeneity; and (4)
shortening of RVOT ARI and QT interval, but not QTc,
T-wave amplitude or duration. These findings demon-
strate that percutaneous SGS is a useful approach for
studying the influence of sympathoexcitation in humans.
To our knowledge, this work represents the first demon-
stration of percutaneous direct stellate ganglion stimula-
tion in humans.
Placement of stimulation catheter
Anesthetic blockade of the stellate ganglion has long been
used for treating a variety of clinical conditions including
complex regional pain syndromes and ventricular arrhyth-
mias (Ackerman and Zhang 2006; Hayase et al. 2013).
Percutaneous stellate ganglion access can be achieved
safely, although it is critical to avoid the vertebral artery.
Table 1. Study subject demographics and stimulation parameters.
Subject Age/Gender LV EF Reason for EP study Stimulation parameters
1 35/F 60% PVC Ablation 10 mA, 5 Hz
2 19/M 63% SVT Ablation 20 mA, 5 Hz
3 37/F 70% PVC Ablation 20 mA, 10 Hz
4 71/M 69% PVC Ablation 10 mA, 10 Hz
5 59/M 50% PVC Ablation 20 mA, 5 Hz
Stimulating 
electrode 
Clavicle 
First  
Rib 
Stellate  
ganglion 
Introducer  
needle 
LEFTA
B
Figure 1. Stimulation and Recording Electrode Set Up. (A) Antero-posterior (AP) fluoroscopic view of the lower cervical and upper thoracic
region, depicting the approach and positioning of the introducer needle and StimuCath electrode for stellate ganglion stimulation. Prior to
stimulation the introducer needle was removed and the stimulating electrode left in place. (B) Right and left anterior oblique fluoroscopic
projections of the thorax, displaying the location of the high right atrial (RA), His bundle, right ventricular (RV), coronary sinus (CS), and right
ventricular outflow tract catheters (RVOT). Unipolar electrograms were recorded with the RVOT catheter.
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Figure 2. Hemodynamic and Electrophysiologic Response to Sympathetic Stimulation. (A) Representative electrocardiographic, electrogram, and
hemodynamic responses to left stellate ganglion stimulation (SGS). (B) An example of ARI measurement from electrogram at baseline and
following SGS. The bars on the QRS downslope and T-wave upslope reflect the interval measured as the ARI. (C) Quantifications of Systolic,
diastolic, mean arterial, and pulse pressures at baseline and during sympathetic stimulation. dP/dt, a marker for cardiac contractility is also
shown. ***P < 0.001. (D) Graphical quantification of atrio-ventricular nodal (A–H: atrio-His) and His-Purkinje (H–V: His-ventricle) conduction at
baseline and following SGS (msec: milliseconds).
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AB
Figure 3. Changes in Activation Recovery Intervals with Stellate Ganglion Stimulation. (A) Individual responses to sympathetic stimulation, with
and without atropine (atr) at baseline and during stellate ganglion stimulation. (B) Dispersion of repolarization (ARImax–ARImin) in each subject.
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We adapted this commonly used technique, and slightly
modified it by advancing the introducer needle slightly
more caudal. For the infusion of an anesthetic, the needle
does not need to be advanced quite to the level of the
first thoracic vertebra, however, to achieve adequate prox-
imity for stimulation, this is necessary. As noted, no com-
plications occurred with adapting the method described
by Abdi et al. (2004).
Hemodynamic responses to left SGS
Our findings are in line with studies from animal models
in that electrical stimulation of the left stellate ganglion
(LSG) increases inotropy but not chronotropy, while right
SGS results in both chronotropy and inotropy (Yanowitz
et al. 1966; Winter et al. 2012; Ajijola et al. 2013b; Zhou
et al. 2013). Ueda et al. (1964), in a canine model
observed chronotropic responses to both right and left
SGS, although it was greater with right than left SGS.
Interestingly, Wong (Wong 1997) observed the opposite
findings, where left SGS resulted in inotropy and chrono-
trophy, and right SGS induced inotropy only. This
discrepancy may be related to the mechanism of stimula-
tion (5 Watt electrocautery) or the patient population
(hyperhidrosis), in whom dysautonomia may be present.
The inotropic findings in the present study are consistent
with the expected effects of left SGS seen in multiple
studies in animal models (Ramirez et al. 2011; Winter
et al. 2012; Ajijola et al. 2013b; Zhou et al. 2013).
Electrophysiologic responses to sympathetic
stimulation
In response to SGS, we observed shortening of the QT
interval. In a porcine model of sympathoexcitation, similar
observations were made, where QT (specifically, ST inter-
val) shortens, with no significant impact on the QTc (Ajij-
ola et al. 2011; Ramirez et al. 2011). In canines, Yanowitz
et al. observed QT interval prolongation following left
stellate ganglionectomy. Interestingly, they also observed
QT prolongation during left SGS. In a noninvasive model
of sympathoexcitation in humans, Findler et al. (2010) also
observed QT interval shortening. Wong observed shorten-
ing of the QTc, although the QT itself is not reported
Figure 4. Electrocardiographic parameters during stellate ganglion stimulation. Shown are the mean responses across all subjects to stellate
ganglion stimulation in QT interval, corrected QT interval (QTc); R-R interval, T-wave duration, T-wave amplitude in Leads II and V5, and Tpeak-
Tend in Leads II and V5 (msec: milliseconds; mV: millivolts).
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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(Wong 1997). These discrepant findings are explained by
the study of Abildskov, where both prolongation and
shortening of the QT interval were observed (Abildskov
1976). Prolongation was observed when sympathetic
stimulation was performed for short durations 3–5 sec,
and shortening induced by prolonged stimulations 30 sec
to 5 min. Stimulation was performed for over 20–30 sec in
our study, as the marker for sympathoexcitation for
enhanced mean arterial pressure. In the Wong study, stim-
ulation was performed for 2 sec (Wong 1997). The mecha-
nism of QT shortening induced by SGS, likely relates to
overall global shortening in action potential duration (Ter-
renoire et al. 2005; Ajijola et al. 2013a; Yagishita et al.
2015) and/or enhanced inotropy (Huang et al. 1992,
1995), as we did not observe an increase in heart rate.
The influence of autonomic tone on intracardiac con-
duction has long been recognized, and stimulation of
parasympathetic elements within the human heart, has
been used to modulate AV conduction (Bianchi et al.
2009). In this study, despite unchanged heart rates, we
observed approximately 10% shortening in the AH inter-
val with no demonstrable effect on the HV interval. This
finding would be expected, given the extensive innerva-
tion of the AV node (Crick et al. 1994; Chow et al.
2001), and already rapid conduction in the Purkinje
fibers. At the level of sympathetic stimulation achieved in
the present study, an effect on AV nodal but not Purkinje
conduction may be expected.
ARI shortening during SGS has been shown in animal
models (Yoshioka et al. 2000; Ajijola et al. 2013a), and in
response to emotional, reflex, and direct sympathetic acti-
vation in humans (Selvaraj et al. 2009; Vaseghi et al.
2012; Child et al. 2014). In our study, we demonstrated
ARI shortening to percutaneous SGS recorded in the
RVOT. Functional studies in porcine and canines demon-
strate that left cardiac sympathetic innervation predomi-
nates on the posterior, inferior, and apical aspects of the
ventricles, while the right predominates on the anterior,
superior, and base of the ventricles (Yanowitz et al. 1966;
Ramirez et al. 2011; Ajijola et al. 2013b) both on the
epicardium and endocardium (Yagishita et al. 2015).
Although panoramic mapping of the human ventricles to
SGS has not been performed, extrapolating from these
animal studies, RSG stimulation may have yielded a
greater increase in ARI shortening measured in the
RVOT. It is also likely that ARIs measured in the poster-
ior aspect of the ventricles may also have shortened more
than the RVOT. The degree of ARI shortening seen with
left SGS in our study is consistent with prior studies in
porcine subjects (Ajijola et al. 2013b; Vaseghi et al. 2013),
where approximately 20–40 msec of ARI shortening
occurred in the RVOT epicardium with left SGS, by
greater than that observed by Child et al. (2014) who
noted a +7 to 15 msec change in ARI. This difference
likely relates to greater sympathoexcitation by low-level
stimulation in our study, relative to mental challenge in
the study by Child and colleagues.
Spatial dispersion of repolarization (DOR) is thought
to be a marker for increased risk of ventricular arrhyth-
mias (Han and Moe 1964; Kuo et al. 1983). In the pres-
ent study, DOR was defined as the difference between the
maximal and minimal ARI recorded in the RVOT. Left
SGS was associated with increased DOR in four out of
five subjects, with the fifth subject showing a decrease. In
canine and porcine studies (Opthof et al. 1991; Ajijola
et al. 2013a), DOR in response to SGS across animals
exhibited similar variability, with some animals showing
an increase, and others, a decrease. Another marker of
dispersion heterogeneity, Tpeak-Tend (Tp-Te), was mea-
sured. Tp-Te in the limb leads is thought to reflect global
DOR, while Tp-Te in the precordial leads reflects trans-
mural DOR (Antzelevitch et al. 2007). We, therefore,
assessed Tp-Te in both limb and precordial leads, but
found no statistically significant increase.
The implications of the present study are multiple.
First, the majority of our understanding of human cardiac
autonomic regulation come from extrapolations of animal
studies, or from studies of indirect (reflex) or mental
stress-induced sympathoexcitation in humans. That per-
cutaneous direct stellate ganglion stimulation can be
achieved safely without significant complications from
catheter placement, or from life-threatening arrhythmias
or hemodynamic disturbances, suggests that this method
of sympathoexcitation may be a valuable research tool.
This is especially true since four of the subjects presented
for ablation of symptomatic and frequent premature
ventricular contractions. Second, hemodynamic, electro-
cardiographic, and electrophysiologic measures of sympa-
thetic stimulation could be readily obtained and
interpreted, indicating that the set up utilized in this
study can be applied relatively readily in other settings.
Additionally, validation of a variety of assumptions and
extrapolations on the workings of the cardiac SNS can be
performed by directly stimulating the stellate ganglion
without the need for surgical exposure of the ganglia.
Limitations
The present study is limited by the small sample size,
although appropriate for the demonstration of feasibility.
Electrograms were recorded from the RVOT only, there-
fore, the impact of SGS on ARIs in other regions of the
heart was not examined. Additionally, SGS was performed
using a unipolar set up, resulting in saturation of the
surface and intracardiac recordings. This limited the
assessment of dynamic changes during SGS.
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Conclusions
In summary, the findings of the present study indicated
that percutaneous low-level SGS in humans is feasible,
has no acute or long-term complications, and yields
meaningful hemodynamic, electrocardiographic, and elec-
trophysiologic data. One patient was on carvedilol (last
dose was the day prior to procedure), however, a signifi-
cant response to SGS was still observed in BP, dP/dt, and
ARI. Further studies utilizing direct stellate ganglion stim-
ulation are warranted to validate existing animal data,
and to identify novel physiologic functions of the sympa-
thetic nervous system in man.
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